Status and phase
Conditions
Treatments
About
To evaluate the efficacy of orelabrutinib combined with R-CHOP vs. R-CHOP alone in the treatment of treatment-naїve mantle cell lymphoma.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Note: Other protocol defined Inclusion/Exclusion criteria may apply.
Primary purpose
Allocation
Interventional model
Masking
356 participants in 2 patient groups
Loading...
Central trial contact
Xinghua Zhao; April Huang
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal